Nancy Fournier, Ph.D., MBA

Nancy Fournier, Ph.D., MBA has a diverse range of work experience. Nancy started their career as a Senior consultant in applied research, strategic initiatives, and partnerships, as well as research funding. Nancy then moved on to become a Clinical Research Associate at Alpha Tau Medical and a Board Member at LOEYS-DIETZ SYNDROME FOUNDATION.

In their recent roles, Nancy served as a Senior Project Manager at the Karen Anthony Consortium, MIDAS project and as a Project Manager at Medical Starpax. Nancy also held the position of President and Chief Executive Officer, Interim at MRM Proteomics Inc.

Prior to that, Nancy worked as the Administrative Director of Proteomics facility at CIUSSS de l'Ouest-de-l'Île-de-Montréal and as a Senior Advisor of Strategic Initiatives at McGill University. Nancy was also a Member of the Board of Directors at the Canadian National Proteomics Network.

Nancy's career also includes serving as the Executive Director of the Ludmer Centre at Université McGill. Overall, they have demonstrated expertise in applied research, project management, leadership, and strategic initiatives in various industries.

Nancy Fournier, Ph.D., MBA pursued their education in two stages. From an unspecified start date until 2009, they attended Université Laval, where they obtained their MBA in Gestion des entreprises (Business Management). Nancy then embarked on their doctoral studies at the same institution, beginning in 1994 and completing them in 1997. During this period, Nancy Fournier specialized in Médecine Expérimentale (Experimental Medicine), culminating in the conferment of their Ph.D. degree.